Ofer Harel, Ph.D. – Re-thinking study design for HIV prevention trials

Abstract: There is a strong push to conduct large-scale randomized controlled study designs in HIV prevention studies. In these randomized controlled studies, the primary research objective is typically to determine the treatment effect based on some biological outcome (e.g. HIV infection). Millions of dollars are spent on these studies and lots of resources are spent […]

Behavioral Economics & HIV Intervention Research Seminar

 Drs. Thomas Rice (UCLA Public Health) and Arleen Leibowitz (CHIPTS Policy Core Director & UCLA Public Affairs) will provide a state-of-the-science overview and discuss possible HIV intervention applications.

Dan J. Stein, Ph.D. – Research Collaborations with Developing Countries: An African Perspective

UCLA AIDS Institute/CFAR Grand Rounds This monthly lecture series, which is offered by the UCLA CFAR / AIDS Institute, consists of hour-long lunchtime lectures, delivered by invited guests or distinguished members of the Institute faculty, on a broad range of subjects. The aims of the program are to highlight important developments in AIDS-related research, encourage […]

New Vaccination Recommendations for LA MSM At-Risk for Invasive Meningococcal Disease

The Los Angeles County Department of Public Health (Public Health) issued new recommendations today for vaccinating against invasive meningococcal disease (IMD) after a recently-identified increase in cases.  The press release reads: “Public Health has now confirmed a total of eight IMD cases in Los Angeles County in 2014. Of these eight cases, four cases were […]

Rishi Manchanda, MD, MPH – How to Leverage Training, Technology, and the ‘Third Sector’ to Improve the Triple Aim and Upstream Drivers of Health

  On  March 13, 2014 – Dr. Rishi Manchanda, President/Founder of HealthBegins, presented on the potential role of social determinants of health in improving the triple aim – i.e. better healthcare quality, population health outcomes, and lower costs. The presentation provided examples of how healthcare professionals, equipped with the tools, technology, and training, can engage […]

Arleen Leibowitz Explains “Cost Effectiveness”

CHIPTS Policy Director Dr. Arleen Leibowitz discusses cost effectiveness analysis and outcomes in the context of HIV prevention.  Click here to review her presentation.

David Wilson – The End of AIDS: The Road to Implementation

David Wilson Director, Global HIV/AIDS Program The World Bank “The End of AIDS: The Road to Implementation”

Curious about PrEP, a prevention strategy that can reduce risk of HIV infection by up to 99 percent?

Learn more by watching, “PrEParing for HIV: An Epidemic Interventions Initiative by the University of California.” HIV/AIDS researchers at the University of California explain how pre-exposure prophylaxis works, and young men share their stories about taking a daily dose of Truvada to preserve their health.”

Keep abreast of breaking news in HIV/AIDS research

Stream and view slides from the Conference on Retroviruses and Opportunistic Infections (CROI) 2104 by going to  http://www.croiwebcasts.org    

Flexible Response to Calif. Budget Crisis Preserved HIV Testing

New research from a team led by CHIPTS Policy Director and Public Policy research professor Arleen Leibowitz shows that local health jurisdictions were able to maintain HIV testing near to pre-recession levels despite a substantial reduction in funding during California’s budget 2009 crisis. As a direct result of state budget cuts that eliminated state funding […]